To the full analysis
Huafon Chemical stock: growth
002064.SZHuafon Chemical reported $3.62B in revenue for fiscal 2025, down 10.3% on the prior year, up 10.4% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
19.9%
per year from 2006 to 2025, per share 11.5%
Earnings (Annual rate)
20%
per year from 2006 to 2025, per share 11.4%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 10.4% | 25.2% | 19.9% |
| Revenue per share | 9.0% | 12.5% | 11.5% |
| Earnings | −4.0% | 22.0% | 20.0% |
| Earnings per share | −5.5% | 9.4% | 11.4% |
| Free cash flow | −5.0% | no data | no data |
| Free cash flow per share | −6.2% | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $114.43M | $8.79M | −$701.78K |
| 2007 | $214.98M | $57.06M | −$25.45M |
| 2008 | $152.32M | $24.54M | −$446.51K |
| 2009 | $179.34M | $16.1M | $34.67M |
| 2010 | $244.12M | $47.96M | $16.15M |
| 2011 | $212.07M | $7.62M | −$23.53M |
| 2012 | $259.04M | $2.76M | −$8M |
| 2013 | $355.78M | $41.5M | −$10.76M |
| 2014 | $354.15M | $61.59M | −$74.51M |
| 2015 | $382.01M | $38.11M | −$120.71M |
| 2016 | $426.53M | −$45.56M | $36.51M |
| 2017 | $622.3M | $57.81M | $39.94M |
| 2018 | $2.27B | $290.45M | $103.22M |
| 2019 | $2.07B | $276.16M | $111.39M |
| 2020 | $2.21B | $341.79M | $394.07M |
| 2021 | $4.25B | $1.19B | $602.9M |
| 2022 | $3.88B | $426.49M | −$5.5M |
| 2023 | $3.94B | $371.68M | $112.78M |
| 2024 | $4.04B | $332.91M | $259.64M |
| 2025 | $3.62B | $278.57M | $305.38M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 14 Mar 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.